BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Ilypsa, Inc. 

5301 Patrick Henry Drive

Santa Clara  California  95054  U.S.A.
Phone: 408-200-9500 Fax: 408-200-9700


SEARCH JOBS




Collaborations

Symyx Technologies, Inc.  High Throughput Experimentation





 Company News
Amgen (AMGN) Completes Acquisition of Ilypsa, Inc. 7/19/2007 12:18:33 PM    More...
Ilypsa, Inc. Announces Promotion of Paul A. Stone to Senior Vice President, General Counsel and Chief Patent Counsel 5/1/2007 12:15:04 PM    More...
Ilypsa, Inc. Completes Enrollment of Phase 2 Clinical Trial of ILY101 For Patients With Chronic Kidney Disease On Hemodialysis 2/6/2007 11:48:40 AM    More...
Ilypsa, Inc. Announces Promotion Of Gerrit Klaerner, Ph.D. To Senior Vice President And Chief Business Officer 12/12/2006 11:41:59 AM    More...
Ilypsa, Inc. Appoints Samuel R. Saks, M.D. To Board Of Directors 12/5/2006 10:55:02 AM    More...
Ilypsa, Inc. Announces Appointment Of William D. Waddill As Chief Financial Officer 10/26/2006 10:39:42 AM    More...
Ilypsa, Inc. And Astellas Pharma Inc. Enter A Licensing Agreement On ILY101 For Treatment Of Hyperphosphatemia In Japan; Astellas To Pay Ilypsa $92 Million 4/27/2006 11:23:51 AM    More...
Ilypsa, Inc. Completes Phase 1 Clinical Trial Of ILY101 For Hyperphosphatemia Associated With Chronic Kidney Disease 4/20/2006 12:01:48 PM    More...
Ilypsa, Inc. Announces Appointment Of Jay P. Shepard As President And CEO 1/5/2006 12:50:45 PM    More...
Ilypsa, Inc. Raises $36 Million For Kidney Drugs 10/19/2005 5:11:57 PM    More...
12

//-->